Clinical trialNCT04476901RecruitingPhase 2Interventional

Administration of Allogeneic-MSC in Patients With Non-Ischemic Dilated Cardiomyopathy

SponsorJoshua M HareEnrollment136Non-ischemic Dilated Cardiomyopathy

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is to evaluate the safety and effectiveness of an experimental drug called human allogeneic mesenchymal stem cell therapy.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Joshua Hare, MD
University of Miami
Principal InvestigatorKOL profile →
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Stanford University
Stanford, California, United States
Phil Yang, MD
Recruiting
University of Miami Miller School of Medicine
Miami, Florida, United States
Josh Hare, MD
Recruiting
University of Louisville
Louisville, Kentucky, United States
Roberto Bolli, MD
Recruiting
Texas Heart Institute
Houston, Texas, United States
Emerson Perin, MD, PhD
Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Allogeneic human mesenchymal stem cells

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 7 May 2021
Primary completion: 30 Apr 2027
Completion: 30 Apr 2027
Last update posted: 24 Mar 2026
Registered enrollment: 136
Registry id: NCT04476901

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.